ABOUT THIS EPISODE
BUFFALO, NY - September 8, 2026 – Oncotarget is proud to support the WIN 2026 Symposium, organized by the Worldwide Innovative Networking (WIN) Consortium, taking place October 2–3, 2026, at the Rhode Island Convention Center in Providence.
The two-day symposium, themed “Precision Oncology: Innovation and Equity Across the Globe,” will bring together researchers, clinicians, healthcare professionals, industry leaders, and other experts from around the world to explore advances in precision oncology and strategies for improving personalized cancer care.
The WIN Consortium is chaired by Wafik S. El-Deiry, MD, PhD, FACP, who also serves as Editor-in-Chief of Oncotarget. Dr. El-Deiry is also the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director of the Legorreta Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
As a peer-reviewed oncology journal dedicated to publishing impactful cancer research, Oncotarget is pleased to support initiatives that encourage international collaboration and advance innovative approaches to cancer prevention, diagnosis, and treatment.
Full press release - https://www.oncotarget.com/news/pr/oncotarget-supports-win-2026-symposium-advancing-precision-oncology/
To learn more about the symposium and registration, visit https://winconsortium.org/symposia
To learn more about Oncotarget, please visit www.oncotarget.com and connect with us:
Facebook - www.facebook.com/Oncotarget/
X - twitter.com/oncotarget
Instagram - www.instagram.com/oncotargetjrnl/
YouTube - www.youtube.com/@OncotargetJournal
LinkedIn - www.linkedin.com/company/oncotarget
Pinterest - www.pinterest.com/oncotarget/
Reddit - www.reddit.com/user/Oncotarget/
Spotify - open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
The two-day symposium, themed “Precision Oncology: Innovation and Equity Across the Globe,” will bring together researchers, clinicians, healthcare professionals, industry leaders, and other experts from around the world to explore advances in precision oncology and strategies for improving personalized cancer care.
The WIN Consortium is chaired by Wafik S. El-Deiry, MD, PhD, FACP, who also serves as Editor-in-Chief of Oncotarget. Dr. El-Deiry is also the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director of the Legorreta Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
As a peer-reviewed oncology journal dedicated to publishing impactful cancer research, Oncotarget is pleased to support initiatives that encourage international collaboration and advance innovative approaches to cancer prevention, diagnosis, and treatment.
Full press release - https://www.oncotarget.com/news/pr/oncotarget-supports-win-2026-symposium-advancing-precision-oncology/
To learn more about the symposium and registration, visit https://winconsortium.org/symposia
To learn more about Oncotarget, please visit www.oncotarget.com and connect with us:
Facebook - www.facebook.com/Oncotarget/
X - twitter.com/oncotarget
Instagram - www.instagram.com/oncotargetjrnl/
YouTube - www.youtube.com/@OncotargetJournal
LinkedIn - www.linkedin.com/company/oncotarget
Pinterest - www.pinterest.com/oncotarget/
Reddit - www.reddit.com/user/Oncotarget/
Spotify - open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
BUFFALO, NY – August 31, 2026 – A new #editorial was published in Volume 17 of Oncotarget on June 8, 2026, titled “Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future perspectives.”
The editorial was led by first and corresponding author Bhartendra Shar…
Pancreatic cancer remains one of the most difficult cancers to treat, in part because mutations in the KRAS gene are extraordinarily common in pancreatic ductal adenocarcinoma (PDAC). These mutations keep growth-promoting signals switched on, allowing cancer cells to proliferate and survive. Althou…
BUFFALO, NY – August 28, 2026 – A new #research paper was published in Volume 17 of Oncotarget on August 19, 2026, titled “Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine.”
The study was led by first author Kelly Crane from the Department of Ur…
BUFFALO, NY – August 25, 2026 – A new precision oncology paper was #published in Volume 17 of Oncotarget on August 14, 2026, titled “Systematic methodological flaws in DNA contamination assessment of mRNA vaccines: A critical analysis of Achs et al. (2025).”
The article was led by first and corres…
BUFFALO, NY – September 1, 2026 – A new #review was published in Volume 17 of Oncotarget on August 28, 2026, titled “Emerging biomedical imaging applications of tumor-derived extracellular vesicles for premetastatic niche detection: Biological rationale, engineering strategies, and translational ch…
Disclaimer: The podcast and artwork embedded on this page are from Oncotarget Podcast, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
